Title
Current status of carbapenemases in Latin America
Date Issued
01 July 2013
Access level
metadata only access
Resource Type
review
Author(s)
Maya J.J.
Ruiz S.J.
Blanco V.M.
Guzman-Blanco M.
Labarca J.
Salles M.
Quinn J.P.
Villegas M.V.
Publisher(s)
Taylor & Francis
Abstract
Enterobacteriaceae and non fermenting Gram-negative bacilli have become a threat to public health, in part due to their resistance to multiple antibiotic classes, which ultimately have led to an increase in morbidity and mortality. β-lactams are currently the mainstay for combating infections caused by these microorganisms, and β-lactamases are the major mechanism of resistance to this class of antibiotics. Within the β-lactamases, carbapenemases pose one of the gravest threats, as they compromise one of our most potent lines of defense, the carbapenems. Carbapenemases are being continuously identified worldwide; and in Latin America, numerous members of these enzymes have been reported. In this region, the high incidence of reports implies that carbapenemases have become a menace and that they are an issue that must be carefully studied and analyzed. © 2013 Informa UK Ltd.
Start page
657
End page
667
Volume
11
Issue
7
Language
English
OCDE Knowledge area
Epidemiología
Salud pública, Salud ambiental
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-84880872131
Source
Expert Review of Anti-Infective Therapy
ISSN of the container
17448336
Sources of information:
Directorio de Producción Científica
Scopus